Delivery Order SPE2DB20D1109-SPE2DB24FP56U

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.38 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $34,017.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of Veklury (Remdesivir) 100 mg vials, a critical medication used for the treatment of COVID-19. This contract does not have any set-aside designations, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,754.64, is for the supply of Veklury (Remdesivir) 100 mg vials, a critical medication used to treat COVID-19. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJQ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,848.80 firm-fixed-price delivery order is for the supply of Veklury (remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VEKLURY (remdesivir) 100 mg vials to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $2,383.22, has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This...
This federal contract award is for the delivery of VEKLURY (Remdesivir) 100 mg vials, a pharmaceutical product used to treat COVID-19, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $22,111.05, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP5W0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm fixed-price delivery order is for the supply of VEKLURY 100 MG vials, a critical COVID-19 treatment medication. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP56U
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,809.20 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has an ultimate completion date of August 14, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical items for military personnel, veterans, and other federal beneficiaries.

This specific contract award was not designated with any set-aside requirements, indicating open competition. The DLA is the primary funding agency, responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, other federal agencies, and international partners.

Generated 2/27/25, 12:48 PM